1.贵州中医药大学第一临床医学院,贵州省贵阳市云岩区宝山北路71号,550001
2.贵州中医药大学第一附属医院
3.山东女子学院
通讯作者:dr.wangling@vip.163.com
收稿:2025-11-10,
修回:2026-04-28,
录用:2026-04-08,
纸质出版:2026-06-02
移动端阅览
张芳,邓东阳,刘晓等.刘尚义从“膜络”论治急性乳腺炎经验[J].中医杂志,2026,67(11):1148-1152.
ZHANG Fang,DENG Dongyang,LIU Xiao,et al.Experience of Professor LIU Shangyi in Treating Acute Mastitis from the Perspective of "Membrane Collaterals"[J].Journal of Traditional Chinese Medicine,2026,67(11):1148-1152.
张芳,邓东阳,刘晓等.刘尚义从“膜络”论治急性乳腺炎经验[J].中医杂志,2026,67(11):1148-1152. DOI: 10.13288/j.11-2166/r.2026.11.003.
ZHANG Fang,DENG Dongyang,LIU Xiao,et al.Experience of Professor LIU Shangyi in Treating Acute Mastitis from the Perspective of "Membrane Collaterals"[J].Journal of Traditional Chinese Medicine,2026,67(11):1148-1152. DOI: 10.13288/j.11-2166/r.2026.11.003.
总结刘尚义教授从“膜络”论治急性乳腺炎的临证经验。认为急性乳腺炎以“膜络郁滞”为发病之本,“湿热痰瘀”为其标,病进则“热毒伤膜”为其变。治疗当以宣膜达郁为先,通膜化毒为要,复膜扶正为宗。临证可据病程分为初期郁热未深、中期毒热渐炽、后期邪退正虚三个阶段,分别以自拟通乳方宣膜达郁、透膜解毒方通膜化毒、托里消毒散加减复膜扶正。
This paper summarizes Professor LIU Shangyi's clinical experience in treating acute mastitis based on the "membrane collaterals" theory. It is considered that constraint and stagnation of the membrane collaterrals is the primary pathogenic factor, with damp, heat, phlegm, and stasis being the secondary manifestations. If untreated, the condition can progress to heat toxin injuring the membrane. In treatme
nt, the emphasis is diffusing and unblocking membrane collaterals, unblocking breast and relieving constraint. The clinical course of the disease can be divided into three stages including the early stage with mild constraint heat, the middle stage with escalating toxic heat, and the later stage with a decline of pathogens but deficiency of healthy
qi
. In correspondence, self-made
Tongru Formula
(通乳方) for diffusing membrane and venting constraint, self-made
Toumo Jiedu Formula
(透膜解毒方) for unblocking membrane and relieving toxin, and
Tuoli Xiaodu Powder
(托里消毒散) with modifications for restoring membrane and rectifying healthy
qi
should be used, respectively.
LOUIS-JACQUES A F , BERWICK M , MITCHELL K B . Risk factors, symptoms, and treatment of lactational mastitis [J]. JAMA , 2023 , 329 ( 7 ): 588 - 589 .
中国妇幼保健协会乳腺保健专业委员会 . 中国哺乳期乳腺炎诊治指南 [J]. 中华乳腺病杂志 (电子版), 2020 , 14 ( 1 ): 10 - 14 .
裴晓华 , 李建蓉 . 中医药诊治乳腺炎的现状与展望 [J] . 北京中医药 , 2025 , 44 ( 6 ): 676 - 680 .
周德楷 , 李南樱 , 冯诗惠 , 等 . 近10年中医药治疗乳痈研究文献可视化分析 [J]. 中国中医药图书情报杂志 , 2025 , 49 ( 1 ): 118 - 123 .
李燕 , 刘尚义 . 国医大师刘尚义教授“膜病”理论分析 [J]. 时珍国医国药 , 2016 , 27 ( 4 ): 977 - 979 .
NAGEL E M , HOWLAND M A , PANDO C , et al . Maternal psychological distress and lactation and breastfeeding outcomes: a narrative review [J]. Clin Ther , 2022 , 44 ( 2 ): 215 - 227 .
SHEN F , ZHOU X , GUO F , et al . Increased risk of postpartum depression in women with lactational mastitis: a cross-sectional study [J]. Front Psychiatry , 2023 , 14 : 1229678 . doi: 10.3389/fpsyt.2023.1229678 http://dx.doi.org/10.3389/fpsyt.2023.1229678 .
DOUGLAS P . Does the academy of breastfeeding medicine's clinical protocol #36 'the mastitis spectrum' promote overtreatment and risk worsened outcomes for breastfeeding families? Commentary [J]. Int Breastfeed J , 2023 , 18 ( 1 ): 51 .
LI D , LI J , YUAN Y , et al . Risk factors and prognosis of acute lactation mastitis developing into a breast abscess: a retrospective longitudinal study in China [J]. PLoS One , 2022 , 17 ( 9 ): e0273967 .
WINK A , MITCHELL J A , LAM S K , et al . Does every patient with lactational mastitis require antibiotic treatment? [J]. Cleve Clin J Med , 2024 , 91 ( 5 ): 283 - 285 .
李燕 , 刘尚义 . 刘尚义治疗膜病经验 [J]. 中医杂志 , 2016 , 57 ( 7 ): 552 - 554 .
陈志良 , 刘聪 , 廖自文 , 等 . 紫花地丁总黄酮的提取工艺及抗炎作用研究 [J]. 中国畜牧兽医 , 2024 , 51 ( 11 ): 5051 - 5063 .
王涛 , 李静 , 卢强 , 等 . 蒲公英黄酮和枯草芽孢杆菌对燕麦青贮品质、抗氧化活性及微生物群落结构的影响 [J]. 草业学报 , 2026 , 35 ( 6 ): 1 - 14 .
宋冰 , 刘学政 . 大黄素对KKAy糖尿病小鼠脂肪组织PPAR-α及PPAR-γ表达影响的实验研究 [J]. 北京中医药大学学报 , 2012 , 35 ( 10 ): 692 - 695 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号